Larry Ellison canceled his plan to sell up to 50 million Oracle shares valued at $7.5 billion, reversing course just one day after the company disclosed the 10b5-1 trading plan in a regulatory filing.
No stock was sold under the plan, which was adopted June 22 and set to end Oct. 24. Oracle confirmed the cancellation Saturday, stating: "No Oracle stock was sold under that plan, and he has no other plans to sell any of his Oracle stock."
The timing is pointed. Oracle shares have fallen 16 percent since June 22 and 23 percent year-to-date. Ellison, 82, retains control of more than 40 percent of Oracle—a position worth roughly $8.75 billion at adoption.
The reversal comes as Oracle faces a critical credibility test on its AI infrastructure bet. The company reported Friday that gross margins shrank, triggering a 1.7 percent stock decline. Investors are demanding proof that Oracle's massive AI spending—underwritten by commitments from OpenAI and others—will eventually drive margin expansion and justify a ballooning debt load.
Oracle disclosed Friday that workforce reduction costs have climbed to $2.8 billion, up $700 million from prior guidance. The job cuts reflect a cash-preservation calculus that now includes keeping Ellison's shares off the market.
For equity investors, the cancellation is a two-edged signal. Ellison's confidence in Oracle's strategic pivot matters—his personal stake aligns him with shareholders. But the decision to scrap the sale also removes a natural price ceiling and suggests management sees near-term trading weakness as temporary. Watch whether Oracle can stabilize margins in its next quarter. If gross margin compression persists, the stock could test lower levels regardless of founder conviction.
Ellison's personal finances extend beyond Oracle. He is backing his son David Ellison's ventures, including the CEO role at Paramount Skydance and a proposed $110 billion acquisition of Warner Bros. Discovery. That deal remains stalled by state attorneys general antitrust litigation.
